Friday, May 27, 2022
High Yields Cannabis/Marijuana/ Weed News
  • Home
  • Cannabis Stocks
  • Cannabis Strains
  • Cannabis Laws
    • Marijuana Laws in All 50 States
    • International Marijuana Laws 2021
  • Product Reviews
  • Growing
  • Write for Us
No Result
View All Result
  • Home
  • Cannabis Stocks
  • Cannabis Strains
  • Cannabis Laws
    • Marijuana Laws in All 50 States
    • International Marijuana Laws 2021
  • Product Reviews
  • Growing
  • Write for Us
No Result
View All Result
High Yields
No Result
View All Result
Home Cannabis Stock Quotes & News

NFL BIOSCIENCES RAISES 5.0 M € FOLLOWING THE SUCCESS OF ITS

Jeremy Vedder by Jeremy Vedder
June 30, 2021
in Cannabis Stock Quotes & News
0
Grapefruit USA, Inc. Announces New Strategic Alliance with

READ ALSO

EnWave Reports 2022 Second Quarter Consolidated Interim

Water Ways Reports Q1 2022 Financial Results Sales of

PRESS RELEASE
Montpellier, June 30, 2021

NFL BIOSCIENCES RISE 5.0 M € FOLLOWING SUCCESS
OF ITS STOCK MARKET INTRODUCTION
SUR EURONEXT GROWTH PARIS®

  • Offer 100% subscribed
  • Offer price set at € 3.80 per share
  • Capital increase for a gross amount of € 5 million
  • Settlement delivery on July 2, 2021 and start of trading on Euronext Growth Paris on July 5, 2021

NFL Biosciences SA, a biopharmaceutical company developing botanical drugs for the treatment of dependencies and addictions, announces the success of its IPO on Euronext Growth Paris® (ISIN: FR0014003XT0, MNEMO: ALNFL).

The operation benefited from subscriptions from historical shareholders, institutional investors and individual investors, sensitive to the global impact on public health of potential innovative treatments, prescription, of natural origin, in the field of addictions and addictions.

For Ignacio Faus, Managing Director of NFL Biosciences: “ We would like to thank all the shareholders, institutional and individuals, who supported us in this capital increase. We will be able to expand the organization with recruitments to support the progress of the clinical study of NFL-101, and initiate the development of the NFL-201 and NFL-301 programs, for the treatment of cannabis addiction and reduction in alcohol consumption. “.

Bruno Lafont, Deputy CEO adds: “ We will now be able to launch the Phase II / III study on 318 patients of our drug candidate NFL-101, already approved in Australia, a country recognized for the quality of its research, and where two centers will be opened in Tasmania during the third quarter 2021. We also intend to open recruitment centers in Europe. “.

Result of the Offer

In the context of the public offer in France made in the form of an open price offer (the ” Open Price Offer “Or the” OPO “) And the global placement for institutional investors (the” Placement Global “) (Together the” Offer ”), A total of 1,315,842 new shares (the“ New Shares ”) were allocated:

  • 486,205 New Shares in the Open Price Offer. Orders A1 and A2 have been allocated in full;
  • 829,637 New Shares in the Global Placement.

The Board of Directors of NFL Biosciences, meeting today, therefore noted the partial exercise of the extension clause and set the price of the Open Price Offer at 3.80 euros per share.

The gross proceeds from the issuance of the New Shares amounted to approximately € 5 million.

Use of funds raised

The funds raised will allow NFL Biosciences to accelerate its development through:

  • the completion of the Phase II / III study of its drug candidate NFL-101;
  • recruiting talent to strengthen the organization;
  • the initiation of the NFL-201 and NFL-301 programs, for the treatment of cannabis addiction and the reduction of alcohol consumption.

Next steps

  • Payment delivery: July 2, 2021
  • Admission of the shares to the Euronext Growth Paris® market and first negotiations: July 5, 2021

Characteristics of the action

Label: NFL Biosciences
Mnemonic code: ALNFL
Code ISIN FR0014003XT0
ICB Classification : 20103010 – Biotechnologie
LEI: 9695006VJWNTN4UNHA27
Eligibility: PEA and PEA-PME

Breakdown of capital and voting rights

Before operation After operation
Undiluted basis Diluted basis(1) Undiluted basis Diluted basis(1)
In number of actions On % In number of actions On % In number of actions On % In number of actions On %
Joël BESSE 979 690 24,99% 1 229 690 20,35% 1 111 253 21,23% 1 361 253 18,50%
LAFONT family 374 390 9,55% 1 124 390 18,60% 377 679 7,22% 1 127 679 15,32%
Gérard LEDUC 76 550 1,95% 1 076 550 17,81% 76 550 1,46% 1 076 550 14,63%
MERAU family 653 050 16,66% 778 050 12,87% 666 206 12,73% 791 206 10,75%
Eric MOREL D’ARLEUX 333 330 8,51% 333 330 5,52% 372 803 7,12% 372 803 5,07%
Nicolas family 275 320 7,03% 275 320 4,56% 275 320 5,26% 275 320 3,74%
Other private 1 226 440 31,30% 1 226 440 20,29% 1 242 358 23,73% 1 242 358 16,88%
Floating – 0,00% – – 1 112 443 21,25% 1 112 443 15,12%
Total 3 918 770 100,00% 6 043 770 100,00% 5 234 612 100,00% 7 359 612 100,00%

(1) Post exercise of:

– 100,000 2018 share subscription warrants (BSA) that can be exercised until July 2, 2023 at a price of 0.50 euros per share, one warrant giving the right to subscribe to 10 shares with a par value of 0.03 euros;

– 12,500 2019 BSA that can be exercised until March 8, 2026 at a price of € 0.30 per share, one warrant giving the right to subscribe to 10 shares with a par value of € 0.03;

– 50,000 share subscription warrants for business creators (BSPCE) 2018 that can be exercised until July 2, 2025 at a price of 0.10 euros per share, one warrant giving the right to subscribe to 10 shares of 0.03 nominal euro;

– 50,000 BSPCE 2019 that can be exercised until March 8, 2026 at a price of € 0.30 per share, one warrant giving the right to subscribe to 10 shares with a par value of € 0.03.

Conservation commitments

As a reminder, commitments to retain Company shares have been signed by a quota of shareholders representing 100% of the existing shares and voting rights of the Company. Said shareholders undertake to keep the shares they hold before the transaction up to:

  • 100% of said shares for a period of 6 months from the admission of the Company’s shares to the Euronext Growth Paris® market, and
  • 50% for a period of 6 months starting at the end of the first period of 6 months.
  • 20210630_NFLBiosciences_CP_Results-IPO_EN_DEF

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0

Related Posts

MedMen’s Tracy McCourt appointed President of West Hollywood cannabis organization
Cannabis Stock Quotes & News

EnWave Reports 2022 Second Quarter Consolidated Interim

May 27, 2022
American Green, Inc.™ (OTC:ERBB) CBD Water with Vessl® Cap
Cannabis Stock Quotes & News

Water Ways Reports Q1 2022 Financial Results Sales of

May 27, 2022
HEXO appoints Chief People & Culture Officer
Cannabis Stock Quotes & News

Resonate Blends partners with California’s top licensed cannabis wholesaling platform, Nabis

May 27, 2022
Fire & Flower and Hifyre announce proposed acquisition of PotGuide
Cannabis Stock Quotes & News

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

May 26, 2022
How to throw the cannabis wedding of your dreams
Cannabis Stock Quotes & News

How to throw the cannabis wedding of your dreams

May 26, 2022
Medical Marijuana, Inc. CEO Featured on Seeking Alpha’s CEO
Cannabis Stock Quotes & News

California cannabis companies brace for environmental law compliance

May 26, 2022
Next Post
Grapefruit USA, Inc. Announces New Strategic Alliance with

Proactive news headlines including BioSig Technologies,

  • Trending
  • Comments
  • Latest
Monthly Spotlight: The Best of Plain Jane CBD

Monthly Spotlight: The Best of Plain Jane CBD

April 8, 2022
The Ultimate Dr. Dabber Stella Vaporizer Review for 2022

The Ultimate Dr. Dabber Stella Vaporizer Review for 2022

April 19, 2022
volcano hybrid review 2022

The 2022 Volcano Hybrid Vaporizer Review: All You Need To Know

May 23, 2022
The Utillian 5 v3 Wax Pen Review for 2022

The Utillian 5 v3 Wax Pen Review for 2022

March 27, 2022

The 7 Best Smell-Proof Weed Bags To Keep Your Bud Stash Safe

April 27, 2022
The Best Synthetic Urine Kit to Pass Your Drug Test in 2022

The Best Synthetic Urine Kit to Pass Your Drug Test in 2022

May 23, 2022
The 10 Best Smell Proof Backpacks for Weed in 2022

The 10 Best Smell Proof Backpacks for Weed in 2022

May 5, 2022
MedMen’s Tracy McCourt appointed President of West Hollywood cannabis organization

EnWave Reports 2022 Second Quarter Consolidated Interim

May 27, 2022
Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

0
Major Marijuana Coalition Forms To Coordinate Legalization Push, But Some Key Advocacy Players Aren’t Involved

Major Marijuana Coalition Forms To Coordinate Legalization Push

0
MMJRecs - cannabis leaf

How Medical Marijuana Can Help Treat Sleep Disorders

0
Colorado Cannabis Sales Exceed $2 Billion in 2020

Colorado Cannabis Sales Exceed $2 Billion in 2020

0
MedMen’s Tracy McCourt appointed President of West Hollywood cannabis organization

EnWave Reports 2022 Second Quarter Consolidated Interim

May 27, 2022
American Green, Inc.™ (OTC:ERBB) CBD Water with Vessl® Cap

Water Ways Reports Q1 2022 Financial Results Sales of

May 27, 2022
HEXO appoints Chief People & Culture Officer

Resonate Blends partners with California’s top licensed cannabis wholesaling platform, Nabis

May 27, 2022
Fire & Flower and Hifyre announce proposed acquisition of PotGuide

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

May 26, 2022

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • March 2020

Categories

  • 1933 Industries
  • 4front Ventures
  • Acreage Holdings
  • Ascend Wellness
  • Ayr Wellness
  • Body & Mind
  • C21 Investments
  • Cannabis Stock Quotes & News
  • Cansortium Inc
  • Captor Capital
  • Ceres Acquisition Corp
  • Chalice Brands
  • Columbia Care
  • Cresco Labs
  • CuraLeaf
  • Gage Growth
  • Glass House Brands
  • Green Thumb Industries
  • Grown Rogue International
  • Harborside
  • Item 9 Labs
  • Jushi Holdings
  • Lowell Farms
  • MariMed
  • MedMen Enterprises
  • News
  • Next Green Wave
  • Planet 13
  • Plus Products
  • Product Reviews
  • Red White & Bloom
  • SLANG Worldwide
  • Sol Global Investments
  • TerrAscend
  • TILT Holdings
  • Trulieve
  • Verano Holdings
  • Vext Sciences
  • Vibe Growth

Recent Posts

  • EnWave Reports 2022 Second Quarter Consolidated Interim
  • Water Ways Reports Q1 2022 Financial Results Sales of
  • Resonate Blends partners with California’s top licensed cannabis wholesaling platform, Nabis
  • New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

QR Code

NFL BIOSCIENCES RAISES 5.0 M € FOLLOWING THE SUCCESS OF ITS
No Result
View All Result
  • Homepages
    • Home Page 1
  • News

© 2021 High Yields